Analyst Ratings For Elevance Health
Portfolio Pulse from Benzinga Insights
Analysts have mixed views on Elevance Health (NYSE:ELV) with recent ratings showing a slight shift towards bullish sentiment. The average 12-month price target has decreased by 4.8% to $573.91. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Elevance Health, a leading U.S. health insurer, has shown strong revenue growth but faces challenges with net margins.
October 18, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Elevance Health has received mixed analyst ratings with a slight bullish shift. The average price target has decreased by 4.8% to $573.91, indicating a cautious outlook. Despite strong revenue growth, the company faces challenges with net margins.
The mixed analyst ratings and the decrease in the average price target suggest a cautious outlook for Elevance Health. While there is a slight bullish sentiment, the reduction in price targets and challenges with net margins balance the positive revenue growth, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100